Prospective pilot study reveals improved weight and caloric intake in underweight NTM lung disease, indicating structured nutritional care is safe and feasible.
Poor nutritional status in nontuberculous mycobacterial pulmonary disease (NTM-PD) is associated with increased mortality and reduced treatment tolerance. In this 12-week prospective, single-arm pilot study, we assessed the feasibility and safety of a structured nutritional program in patients with NTM-PD who are underweight. Patients with NTM-PD with body mass index (BMI) < 19 kg/m 2 , unintentional weight loss within the past year, or anorexia were included. The intervention involved individualized nutritional counseling delivered by a registered dietitian, biweekly follow-up assessments, and daily oral nutritional supplementation (two packs; 200 kcal/200 mL per pack). Eleven patients were enrolled, and 10 completed the study (median age 69.5 years [interquartile range 58.0–72.0]; 90% female; BMI 16.5 kg/m 2 [16.2–18.6]). The intervention was well tolerated, and most participants achieved the predefined adherence threshold. Mild gastrointestinal symptoms were reported (abdominal fullness 30%, indigestion 10%), with no serious adverse events. Total daily energy intake increased from 1354 to 1950 kcal/day ( P = 0.002), and body weight increased from 43.0 to 45.6 kg ( P = 0.018). This pilot trial supports the feasibility and safety of a structured nutritional program in patients with NTM-PD who are underweight and provides a basis for progression to a larger, adequately powered definitive trial.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: